T. Murray
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 2
- Toxicology top 10%
- Pharmaceutical Science top 10%
-
- Radiopharmaceutical Chemistry and Applications 6
- Medical Imaging Techniques and Applications 4
- Corneal Surgery and Treatments 1
-
- Medical Imaging and Pathology Studies 3
-
- Orthopaedic implants and arthroplasty 1
-
- Air Quality and Health Impacts 1
-
- Pain Mechanisms and Treatments 1
- Co-authors
- T. E. HilditchJ CassidyRachel MorrisonAlison H. ThomsonRuth DuncanS S BurtlesPeter D. WilsonLilian S. Murray
- Cited by
- BiomaterialsOncologyToxicology
- Journals
- Nuclear Medicine Communications (7 papers)Neuropharmacology (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
T. Murray
20 papers receiving 888 citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Biomaterials 360
- Oncology 177
- Toxicology 20
- Pharmaceutical Science 33
- Polymers and Plastics 73
Countries citing papers authored by T. Murray
This map shows the geographic impact of T. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Murray more than expected).
Fields of papers citing papers by T. Murray
This network shows the impact of papers produced by T. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Murray. The network helps show where T. Murray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T. Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 115 | |
| 2 | 2010 | 1 | |
| 3 | 2007 | 2 | |
| 4 | 2005 | 10 | |
| 5 | 2004 | 1 | |
| 6 | 2003 | 12 | |
| 7 | 2000 | 1 | |
| 8 | 2000 | 6 | |
| 9 | Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.breakdown → | 1999 | 574 |
| 10 | 1993 | 12 | |
| 11 | 1992 | 68 | |
| 12 | 1992 | 16 | |
| 13 | 1991 | 2 | |
| 14 | 1991 | 25 | |
| 15 | 1990 | 8 | |
| 16 | 1990 | 5 | |
| 17 | 1988 | 19 | |
| 18 | 1988 | 1 | |
| 19 | 1986 | 5 | |
| 20 | Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. | 1986 | 29 |
About T. Murray
T. Murray is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Radiation, having authored 21 papers that have together received 913 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Medical Imaging Techniques and Applications (4 papers), Medical Imaging and Pathology Studies (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Orthopaedic implants and arthroplasty (1 paper), Air Quality and Health Impacts (1 paper), Corneal Surgery and Treatments (1 paper) and Pain Mechanisms and Treatments (1 paper). The work is most often cited by research in Biomaterials (360 citations), Oncology (177 citations) and Toxicology (20 citations). T. Murray has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include T. E. Hilditch, J Cassidy, Rachel Morrison, Alison H. Thomson, Ruth Duncan, S S Burtles, Peter D. Wilson, Lilian S. Murray, P. Vasey and E. Frigerio. Their work appears in journals such as Nuclear Medicine Communications, Neuropharmacology, British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Health Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.